ASHLEE BLAKESLEE: Open Payments
NPI 1508398439 · EVANS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$844 in 41 payments from 12 companies in 2025. Trend: 2023 $935 · 2024 $1,029 · 2025 $844
Food & beverage: $841Education: $3
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $216 |
| Novo Nordisk Inc | 5 | $115 |
| Novartis Pharmaceuticals Corporation | 4 | $82 |
| Boston Scientific Corporation | 2 | $76 |
| Merck Sharp & Dohme LLC | 4 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $69 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| ABIOMED | 2 | $47 |
| Edwards Lifesciences Corporation | 2 | $44 |
| Amgen Inc. | 2 | $31 |
Products named: ELIQUIS, Wegovy, VYNDAQEL, LEQVIO, VERQUVO, JARDIANCE, EMBLEM MRI S-ICD, SAPIEN 3 Ultra RESILIA.
Industry payments across GA — which companies pay providers there.
